HistoSonics has developed a non-invasive, sonic beam therapy platform that uses histotripsy, capable of destroying targeted liver tumors at a sub-cellular level
Minneapolis, MN
Joined September 2019
- Tweets129
- Following55
- Followers1.3K
- Likes65
HistoSonics, Inc. is ready to connect with you at #IHPBA in Singapore on October 28-31st. Join us for a Lunch Symposium on Thursday, Oct 29 and stop by booth #F06 for an Innovation Session on Friday, Oct 30 from 9:30-10:00 to learn more about the Edison #Histotripsy System.
@HistoSonics just concluded this year’s #HistotripsySummit in Phoenix, AZ. This annual gathering brought together over 300 attendees from across the growing, multidisciplinary #histotripsy community to advance patient care.
Are you attending #ASTRO2026 in Boston or #ACS2026 in Washington this weekend? Stop by the HistoSonics booth for a discussion and hands-on live demonstration of the Edison #Histotripsy System!
Join us this week for an insightful discussion on #histotripsy for liver tumors. Looking forward to an engaging conversation around the current treatment landscape, patient selection, ongoing research, and multidisciplinary care. 242981120.hs-sites-na2.com/r…
HistoSonics, Inc. retweeted
At @Samsung_HC , innovation begins with a shared purpose: finding better solutions for patients.
This week, we welcomed our strategic partner @histosonics to explore how the combination of their pioneering technology and Samsung's advanced imaging can expand the possibilities of non-invasive patient care.
Seeing the technology in action was more than a demonstration, it was an opportunity to exchange insights, challenge ideas, and take another step toward advancing technologies that can improve patient care.
Together, we will continue exploring what's possible and turning innovation into meaningful clinical value.
#SamsungHealthcare #HistoSonics
The @UMich opened the new $10M #Histotripsy Center, a research and education facility dedicated to advancing histotripsy and exploring new applications across organs and treatment areas. news.engin.umich.edu/2026/09…
📢Just a few days away! If you're heading to #CIRSE2026 in Copenhagen, connect with the HistoSonics team and add these two events to your schedule on Monday, September 7th.
Join us! Register for a Live Webinar – #Histotripsy for Liver Tumors: Current Experience and Considerations for Medical Oncologists
🗓️ Thursday, September 24th
🕔 5:00 PM CT / 6:00 PM ET
242981120.hs-sites-na2.com/r…
HistoSonics is ready to connect with you at the @cirsesociety Annual Congress in Copenhagen, Denmark on September 5-9th. Join us for a Lunch Symposium and celebrate our recent CE Mark! Stop by Booth #23 for discussions about the Edison #Histotripsy System. #CIRSE2026
If you're attending the @socroboticsurg meeting this week in Florida, don’t miss the below sessions for an opportunity to hear from #HistoSonics leaders. #SRS2026 #Histotripsy
HistoSonics announces the opening of its expanded Histotripsy Training Center in Hong Kong, reinforcing the city's position as a leading hub for physician education, clinical collaboration, and innovation in Asia.
businesswire.com/news/home/2… #histosonics #histotripsy
HistoSonics has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other markets that recognize the CE Mark. businesswire.com/news/home/2…
At HistoSonics, our mission is to deliver #NewHope to patients who need it most. Julie’s story is one of resilience and serves as a powerful reminder of the impact #histotripsy can have by expanding treatment options for patients around the world. vimeo.com/1207387092
HistoSonics is honored to announce a new financing round with participation from Yosemite, alongside several strategic investors who share our commitment to advancing non-invasive histotripsy. businesswire.com/news/home/2…
HistoSonics is ready to connect with you at the @ATCMeeting June 20-24th in Boston. Stop by Booth #621 for a discussion and hands-on live demonstration of the Edison #Histotripsy System.
#HistoSonics has received approval from the Taiwan Food and Drug Administration (#TFDA) for the Edison® System, representing a significant milestone in the company’s global expansion efforts and continued growth across Asia. #histotripsy businesswire.com/news/home/2…
#HistoSonics announced it has submitted a De Novo request to the U.S. Food and Drug Administration seeking authorization to expand the use of its Edison® #Histotripsy System to include the destruction of kidney (renal) tumors. businesswire.com/news/home/2…
Hear from #histotripsy experts at #AUA26. Two Device Tech Talk opportunities at @AmerUrological Annual Meeting in Washington, DC; Exhibit Hall Booth #2161.
We are honored to share that #HistoSonics, Inc. has been named one of @TIME's 10 Most Influential Companies in Health & Life Sciences for 2026 as part of the inaugural #TIME100 Companies Industry Leaders list. #TIME100CompaniesIndustryLeader time.com/article/2026/04/27/…
Chairman and CEO, Mike Blue, looks forward to the Keynote Interview at @DeviceTalks Minnesota on May 4th discussing our 2025 management-led majority stake acquisition for $2.25B, the new syndicate of globally recognized private and public investors and more. #DeviceTalksMinnesota
